RAMELDA

This brand name is authorized in Turkey

Active ingredients

The drug RAMELDA contains one active pharmaceutical ingredient (API):

1 Ramelteon UNII 901AS54I69 - RAMELTEON
Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT₁ and MT₂ receptors and relative selectivity over the MT₃ receptor. The activity of ramelteon at the MT₁ and MT₂receptors is believed to contribute to its sleep-promoting properties, as these receptors, acted upon by endogenous melatonin, are thought to be involved in the maintenance of the circadian rhythm underlying the normal sleep-wake cycle. Read about Ramelteon

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05CH02	Ramelteon	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CH Melatonin receptor agonists
Discover more medicines within N05CH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699514094050, 8699514094067

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.